Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMALIZUMAB vs OMAVELOXOLONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OMALIZUMAB vs OMAVELOXOLONE: Safety Overview

Metric OMALIZUMAB OMAVELOXOLONE
Total FAERS Reports 63,846 1,249
Deaths Reported 1,713 54
Death Rate 2.7% 4.3%
Hospitalizations 11,178 304
Average Patient Age 51.0 yrs 38.1 yrs
% Female Patients 72.5% 47.0%
FDA Approval Date N/A Feb 28, 2023
Manufacturer CELLTRION, Inc. Biogen
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription